A female patient is taking filgrastim (Neupogen) to decrease the incidence of infection. The nurse notices a small increase in the neutrophil count 2 days after starting therapy. The nurse's evaluation of the increase is
...
A female patient is taking filgrastim (Neupogen) to decrease the incidence of infection. The nurse notices a small increase in the neutrophil count 2 days after starting therapy. The nurse's evaluation of the increase is that
A the therapeutic effect of the drug is slow, and it is likely to
. cause adverse effects.
B the therapeutic effect of the drug is fully evident.
.
C the drug therapy is proving to be ineffective.
.
D the increase in the neutrophil count is only transient.
.
QUESTION 2
Which of the following patients will be at the greatest risk for anemia and would be the most likely candidate for epoetin alfa therapy?
A A 62-year-old male with cancer
.
B A 40-year-old male with a high white blood
. cell count
C A 20-year-old female
.
D A 30-year-old pregnant woman
.
QUESTION 3
A male patient is receiving rituximab therapy for non-Hodgkin's lymphoma. Which of the following would be a priority nursing intervention to reduce the risk for cytotoxicity and tumor lysis syndrome?
A Ensure that the patient maintains a normal fluid and
. electrolyte balance.
B Monitor the patient for deterioration in renal function.
.
C Protect the patient from exposure to infections.
.
D Ensure that the patient maintains a normal breathing
. pattern.
QUESTION 4
A male patient is receiving heparin by continuous intravenous infusion. The nurse will instruct the patient and family members to report which of the following should it occur?
A Presence of blood in urine or stools
.
B Sudden occurrence of sleepiness and
. drowsiness
CONTINUED.........
[Show More]